<DOC>
	<DOCNO>NCT00806143</DOCNO>
	<brief_summary>Repetitive transcranial magnetic stimulation ( rTMS ) recently FDA approve treatment resistant depression . No accordance exist involve mechanism action stimulation parameter , frequency side optimal .</brief_summary>
	<brief_title>Bilateral Versus Monolateral Repetitive Transcranial Stimulation Depression</brief_title>
	<detailed_description>To compare different procedure study patient unipolar recurrent resistant major depressive disorder double-blind , control trial randomize either sequential bilaterally right leave dorsolateral prefrontal cortex ( DLPFC ) monolaterally right DLPFC . Patients randomize receive sequentially low-frequency rTMS 1 Hz right DLPFC high-frequency rTMS 10 Hz rTMS leave DLPFC , receive low-frequency rTMS 1 Hz right DLPFC . Significant antidepressant effect express reduction Hamilton Depression Scale score record group patient .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Diagnostic Statistical ManualIV criterion Depressive Major Episode Hamilton Rating Scale Depression 28 ( HamD ) score â‰¥ 18 Failure respond minimum two course antidepressant medication least 6 week Any comorbid axis I disorder ( except simple social phobia ) Any significant medical , particularly neurologic , illness ( seizure , head trauma brain lesion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Depression</keyword>
	<keyword>TMS</keyword>
</DOC>